Orlando Health, Inc.
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Endoscopic ultrasound (EUS)-guided interventions are becoming the first-line treatment of various pancreaticobiliary disorders such as malignant biliary obstruction, access to bile duct or pancreatic duct after failed ERCP, and drainage of pancreatic, peripancreatic or intraabdominal fluid collections. However, given the lack of dedicated devices for performing these complex interventions, accessories used to perform endoscopic retrograde cholangiopancreatography (ERCP) are currently being used off-label to perform most interventional EUS procedures. The RIVOS™ EUS access device is a novel, F…
Inclusion Criteria: * Age ≥ 18 years * All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device Exclusion Criteria: * Age \< 18 years * Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device
EUS-guided intervention using the RIVOS™ EUS access device
Arctuva estimate
Verify or correct the compensation shown for this listing.